These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 3219124)
1. [Synthesis of tritium-labelled prostaglandin E1 and its binding to human platelets]. Shevchenko VP; Nagaev IIu; Vrzheshch PV; Ershov DE; Zaĭtsev SV Bioorg Khim; 1988 Aug; 14(8):1075-85. PubMed ID: 3219124 [TBL] [Abstract][Full Text] [Related]
2. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood. Kikura M; Kazama T; Ikeda T; Sato S Platelets; 2000 Dec; 11(8):446-58. PubMed ID: 11177444 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP. Harfenist EJ; Packham MA; Mustard JF Thromb Haemost; 1985 Apr; 53(2):183-7. PubMed ID: 3927504 [TBL] [Abstract][Full Text] [Related]
4. Migraine: possible role of platelet insensitivity to prostaglandin E1 (PGE1). Cerneca F; de Luyk S; Radillo O; Simeone R; Mangiarotti M Funct Neurol; 1993; 8(6):403-8. PubMed ID: 8150318 [TBL] [Abstract][Full Text] [Related]
5. [Effect of prostaglandins E1 and E2 on thrombocyte form and aggregation]. Antonikov IM; Alekseev OV; Chernukh AM Biull Eksp Biol Med; 1982 Apr; 93(4):11-3. PubMed ID: 6952942 [TBL] [Abstract][Full Text] [Related]
6. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study. Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469 [TBL] [Abstract][Full Text] [Related]
7. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production. Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415 [TBL] [Abstract][Full Text] [Related]
8. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen. Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change. Steen VM; Holmsen H Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615 [TBL] [Abstract][Full Text] [Related]
10. Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor. McDonald JW; Stuart RK J Lab Clin Med; 1974 Jul; 84(1):111-21. PubMed ID: 4365532 [TBL] [Abstract][Full Text] [Related]
11. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976 [TBL] [Abstract][Full Text] [Related]
12. The effect of parenteral lipid emulsion-induced hyperlipidemia on prostaglandin E1 modulation of platelet function. Saladino CF; Kosacolsky-Singer C; Fox R; Nethala V; Feffer SE; Jonas EA Artery; 1993; 20(6):303-13. PubMed ID: 8010886 [TBL] [Abstract][Full Text] [Related]
13. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor. Pampuch A; Cerletti C; de Gaetano G Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371 [TBL] [Abstract][Full Text] [Related]
14. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb. Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin. Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511 [TBL] [Abstract][Full Text] [Related]
16. Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives. Peerschke EI; Galanakis DK J Lab Clin Med; 1983 Mar; 101(3):453-60. PubMed ID: 6827176 [TBL] [Abstract][Full Text] [Related]
17. Cationized ferritin as a platelet-stimulating surface probe. Binding to platelets and effects on platelet function. Patscheke H; Dierichs R Eur J Cell Biol; 1986 Mar; 40(1):64-71. PubMed ID: 3084260 [TBL] [Abstract][Full Text] [Related]
18. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation. Zahavi M; Zahavi J; Kakkar VV Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048 [TBL] [Abstract][Full Text] [Related]
19. [Preparation and properties of prostaglandin D2 labelled with tritium with high molar radioactivity]. Shram SI; Vrzheshch PV; Bobrovich OA; Tatarintsev AV; Shevchenko VP; Miasoedov NF Bioorg Khim; 1989 Sep; 15(9):1274-80. PubMed ID: 2590255 [TBL] [Abstract][Full Text] [Related]
20. Interaction of beta 2-glycoprotein-I with human blood platelets: influence upon the ADP-induced aggregation. Nimpf J; Wurm H; Kostner GM Thromb Haemost; 1985 Aug; 54(2):397-401. PubMed ID: 4082080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]